UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$388M |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$359M |
| 3 |
ExxonMobil
XOM
|
+$284M |
| 4 |
TSMC
TSM
|
+$259M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$239M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$911M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$825M |
| 3 |
UBS Group
UBS
|
+$683M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$381M |
| 5 |
Willis Towers Watson
WTW
|
+$375M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.08% |
| 2 | Financials | 7.19% |
| 3 | Healthcare | 6.35% |
| 4 | Consumer Discretionary | 5.55% |
| 5 | Industrials | 4.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Boston Scientific
BSX
$69.2B
| $244M | 0.08% |
5,516,020
+205,393
| +4% | +$8.9M |
|
252
Prologis
PLD
$131B
| $240M | 0.08% |
1,489,140
+435,444
| +41% | +$66.4M |
|
253
Marvell Technology
MRVL
$189B
| $240M | 0.08% |
3,351,936
+309,161
| +10% | +$22.3M |
|
254
Emerson Electric
EMR
$91B
| $240M | 0.08% |
2,449,382
-153,830
| -6% | -$14.6M |
|
255
First Trust NASDAQ Cybersecurity ETF
CIBR
$15.2B
| $240M | 0.08% |
4,509,774
+383,060
| +9% | +$18.7M |
|
256
State Street SPDR S&P Dividend ETF
SDY
$23.8B
| $239M | 0.08% |
1,863,740
+154,885
| +9% | +$19.6M |
|
257
PUT
AbbVie
ABBV
$435B
| $237M | 0.08% |
1,464,300
-1,116,174
| -43% | -$162M |
|
258
Travelers Companies
TRV
$79.8B
| $236M | 0.08% |
1,293,530
-358,617
| -22% | -$61.5M |
|
259
Incyte
INCY
$24.3B
| $233M | 0.08% |
2,936,589
+1,973,236
| +205% | +$144M |
|
260
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.2B
| $232M | 0.08% |
4,504,878
+263,045
| +6% | +$14M |
|
261
Dow Inc
DOW
$21.4B
| $231M | 0.08% |
3,619,634
-634,905
| -15% | -$38.3M |
|
262
First Trust Rising Dividend Achievers ETF
RDVY
$25.6B
| $230M | 0.08% |
4,695,748
+775,129
| +20% | +$38.7M |
|
263
Altria Group
MO
$114B
| $229M | 0.08% |
4,381,599
-546,525
| -11% | -$27.8M |
|
264
iShares Preferred and Income Securities ETF
PFF
$13.3B
| $227M | 0.08% |
6,221,065
-1,112,324
| -15% | -$40.9M |
|
265
Williams Companies
WMB
$87.8B
| $224M | 0.07% |
6,701,399
+347,393
| +5% | +$10.6M |
|
266
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.7B
| $223M | 0.07% |
5,347,248
+1,256,815
| +31% | +$51.8M |
|
267
VF Corp
VFC
$5.98B
| $221M | 0.07% |
3,891,988
-260,708
| -6% | -$16.2M |
|
268
BioMarin Pharmaceuticals
BMRN
$11.6B
| $221M | 0.07% |
2,861,503
+2,697,524
| +1,645% | +$226M |
|
269
iShares Russell Mid-Cap Value ETF
IWS
$15.9B
| $220M | 0.07% |
1,839,603
+148,704
| +9% | +$17.5M |
|
270
iShares Floating Rate Bond ETF
FLOT
$10.3B
| $220M | 0.07% |
4,354,461
+1,251,216
| +40% | +$63.3M |
|
271
PUT
VanEck Gold Miners ETF
GDX
$25.5B
| $220M | 0.07% |
5,727,600
-4,980,900
| -47% | -$169M |
|
272
PUT
Mastercard
MA
$500B
| $218M | 0.07% |
609,621
+158,721
| +35% | +$57.1M |
|
273
PUT
CVS Health
CVS
$126B
| $216M | 0.07% |
2,138,500
-777,400
| -27% | -$81.7M |
|
274
Vanguard Financials ETF
VFH
$13.8B
| $216M | 0.07% |
2,307,926
+158,869
| +7% | +$15.2M |
|
275
Norfolk Southern
NSC
$76.8B
| $215M | 0.07% |
754,755
+20,794
| +3% | +$5.73M |
|
Similar funds
UBS Group's Q1 2022 Portfolio in Review
As of Q1 2022, UBS Group held 11,668 positions worth $300B, down 14% from $349B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group withdrew a net $29.5B in Q1 2022, closing 1,160 positions and reducing 5,175 holdings. Its most notable exit was Xilinx Inc, an estimated $186M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, UBS Group opened a new position in Shell worth $66.6M.
- UBS Group's largest Q1 2022 buy was Shell: 1,213,213 shares worth $66.6M.
- UBS Group added most to Tesla in Q1 2022, an estimated $388M increase.
- UBS Group's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $911M.
- UBS Group fully exited Xilinx Inc in Q1 2022, selling an estimated $186M.
- UBS Group's ten largest holdings make up 13% of its $300B portfolio in Q1 2022.
- UBS Group opened 1,182 new positions and closed 1,160 in Q1 2022.
- UBS Group's portfolio value fell 14% quarter-over-quarter to $300B.
Based on UBS Group's 13F filing for Q1 2022, filed 16 May 2022.